Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant trading activity in Advanced Medical Solutions Group plc (AMS.L) ordinary shares.
The disclosure was made under Rule 8.5 of the UK Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, operating as an exempt principal trader connected to the offer process surrounding Advanced Medical Solutions Group.
The bank holds a notable advisory role in this matter, with the filing confirming that Investec is Advisor and Joint Broker to Advanced Medical Solutions Group plc.
The dealings were undertaken on 9th July 2026, with the formal public disclosure submitted to a Regulatory Information Service on 10th July 2026.
According to the filing, Investec purchased 164,730 ordinary shares in Advanced Medical Solutions Group at a price of 278.75 pence per unit during the dealing period.
Separately, the bank also sold 400,000 ordinary shares in the company, also transacted at a uniform price of 278.75 pence per unit.
The filing confirms that no cash-settled derivative transactions, stock-settled derivative transactions, or options were exercised or written as part of these dealings.
Investec further disclosed that no indemnity arrangements, option agreements, or other formal or informal understandings exist that could serve as an inducement to deal or refrain from dealing in the relevant securities.
Similarly, the bank confirmed there are no agreements or understandings relating to voting rights or future acquisition or disposal of any securities to which a derivative is referenced.
The contact listed on the disclosure is Abhishek Gawde, reachable by telephone for any queries relating to the filing.
Regulatory disclosures of this nature are a standard requirement under the UK Takeover Code whenever a connected party undertakes dealings in securities of a company subject to a formal offer process.
